Abstract
Coronaviruses are important human and animal pathogens of the order Nidovirales. Several new members were discovered following the emergence of SARS-CoV in human populations, including two human coronaviruses and several animal coronaviruses. They cause respiratory and gastrointestinal illnesses and have been found in the brains of patients with multiple sclerosis. The high mortality of SARS, the identification of a natural reservoir, and the well-founded fear of provoking antibody-enhanced disease as a result of vaccination fueled the ongoing efforts in anti-coronavirus drug discovery. This review presents the results of current research.
Keywords: Coronavirus, SARS-CoV, Severe acute respiratory syndrome, SARS, main protease, 3CLpro, polymerase, helicase, interferon, interferon-inducer
Infectious Disorders - Drug Targets
Title: Drug Targets in Severe Acute Respiratory Syndrome (SARS) Virus and other Coronavirus Infections
Volume: 9 Issue: 2
Author(s): Tommy R. Tong
Affiliation:
Keywords: Coronavirus, SARS-CoV, Severe acute respiratory syndrome, SARS, main protease, 3CLpro, polymerase, helicase, interferon, interferon-inducer
Abstract: Coronaviruses are important human and animal pathogens of the order Nidovirales. Several new members were discovered following the emergence of SARS-CoV in human populations, including two human coronaviruses and several animal coronaviruses. They cause respiratory and gastrointestinal illnesses and have been found in the brains of patients with multiple sclerosis. The high mortality of SARS, the identification of a natural reservoir, and the well-founded fear of provoking antibody-enhanced disease as a result of vaccination fueled the ongoing efforts in anti-coronavirus drug discovery. This review presents the results of current research.
Export Options
About this article
Cite this article as:
Tong R. Tommy, Drug Targets in Severe Acute Respiratory Syndrome (SARS) Virus and other Coronavirus Infections, Infectious Disorders - Drug Targets 2009; 9 (2) . https://dx.doi.org/10.2174/187152609787847659
DOI https://dx.doi.org/10.2174/187152609787847659 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design Response to HAART in Treatment-Naive HIV-Infected Patients with a Prior Diagnosis of Tuberculosis or other Opportunistic Infections
Current HIV Research Nanodiamonds as a New Horizon for Pharmaceutical and Biomedical Applications
Current Drug Delivery Meet Our Editorial Board Member
Current Drug Therapy Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Current Cancer Drug Targets Advances in Lentiviral Vectors: A Patent Review
Recent Patents on DNA & Gene Sequences Immunotherapeutic Options for Pediatric Malignancies
Current Immunology Reviews (Discontinued) New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design Strategies to Improve the Killing of Tumors Using Temozolomide: Targeting the DNA Repair Protein MGMT
Current Medicinal Chemistry MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers Multimodality Imaging of CXCR4 in Cancer: Current Status towards Clinical Translation
Current Molecular Medicine Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target
Current Medicinal Chemistry Study of HIV Resistance Mutations Against Antiretrovirals using Bioinformatics Tools
Current HIV Research Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier
Current Cancer Drug Targets Synthetic Chemistry with N-Acyliminium Ions Derived from Piperazine-2,5-Diones and Related Compounds
Current Organic Synthesis Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways
Current Cancer Drug Targets Prediction and Early Evaluation of Anticancer Therapy Response: From Imaging of Drug Efflux Pumps to Targeted Therapy Response
Current Medicinal Chemistry Smart Drug-Delivery Systems for Cancer Nanotherapy
Current Drug Targets Recent Advances in the New Generation Taxane Anticancer Agents
Medicinal Chemistry Thalidomide Analogues as Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery